Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ulcerative colitis
Recent news which mentions ulcerative colitis
Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis
April 07, 2022
Tickers
MCRB
Tags
MCRB
General
Small Cap
From
Benzinga
Pfizer's Ulcerative Colitis Candidate Aces Late-Stage Study
March 23, 2022
Tickers
PFE
Tags
Briefs
News
PFE
From
Benzinga
Janssen's Tremfya Shows Clinical Response At 12 Weeks In Ulcerative Colitis
February 18, 2022
Tickers
JNJ
Tags
Biotech
JNJ
Health Care
From
Benzinga
Nearly 66% Of Patients Respond To Eli Lilly's Mirikizumab In Ulcerative Colitis Study
February 18, 2022
Tickers
LLY
Tags
General
Market News
News
From
Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
January 10, 2022
Tickers
GLMD
Tags
Penny Stocks
Trading Ideas
Health Care
From
Benzinga
Seres Posts Interim Microbiome Data Analysis From Failed Ulcerative Colitis Study
December 16, 2021
Tickers
MCRB
Tags
General
Small Cap
MCRB
From
Benzinga
Bristol Myers' Zeposia Wins European Approval For Ulcerative Colitis
November 23, 2021
Tickers
BMY
Tags
Benzinga
Health Care
Biotech
From
Benzinga
Ventyx Jumps Over 20% Today After NASDAQ Debut
October 21, 2021
Tickers
BMY
FPX
IPO
IPOS
Tags
FPX
ulcerative colitis
News
From
Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
October 07, 2021
Tickers
BMY
Tags
Briefs
Biotech
Movers
From
Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
October 05, 2021
Tickers
KLDO
Tags
KLDO
Market News
why it's moving
From
Benzinga
Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
October 05, 2021
Tickers
GLPG
GLPGF
Tags
Market News
General
GLPG
From
Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
October 01, 2021
Tickers
LLY
Tags
Phase 2 Trial
Market News
General
From
Benzinga
AbbVie Submits Upadacitinib Applications In US, Europe For Ulcerative Colitis
September 16, 2021
Tickers
ABBV
Tags
News
Briefs
ulcerative colitis
From
Benzinga
Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study
August 24, 2021
Tickers
TBPH
Tags
Market News
Downgrades
Analyst Color
From
Benzinga
Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study
August 24, 2021
Tickers
JNJ
TBPH
Tags
Phase 2 Trial
Crohn's Disease
TBPH
From
Benzinga
Seres Therapeutics Stock Plunges As Ulcerative Colitis Candidate Disappoints In Mid-Stage Study
July 22, 2021
Tickers
MCRB
Tags
Phase 2 Trial
Small Cap
General
From
Benzinga
Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients
July 15, 2021
Tickers
GLPG
GLPGF
Tags
Health Care
Benzinga
Biotech
From
Benzinga
Eli Lilly's Mirikizumab Shows Mucosal Healing In Ulcerative Colitis Maintained For Up To One Year
July 09, 2021
Tickers
LLY
Tags
News
Briefs
ulcerative colitis
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.